Project Grant HT94252310733
Award Date
9/15/23
Completion Date
9/14/26
Dollars Obligated
$733K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Mississippi State, MS 39762, USA
Similar Awards
The Defense Health Agency awarded a $1,397,266 project grant to The University of Queensland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 through February 28, 2026 to develop peptide inhibitors targeting sodium channels for the treatment of Amyotrophic Lateral Sclerosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command awarded a $564,698.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M Engineering Experiment Station (Tees) to develop "Engineered Therapeutic Extracellular Vesicles to Resolve Pyridostigmine Bromide-Induced Enteric Neuroinflammation in Gulf War Illness." The grant, with a performance period from November 1, 2024 to October 31, 2027, will support advanced biomedical research...
Montclair State University received a $979,186 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the development of potent PFPKG inhibitors for malaria chemoprotection. The 4-year project, which commenced on July 15, 2023, aims to develop novel compounds that can prevent malaria infections. Through this federal grant, the university will leverage its expertise in structure-guided drug design to advance...
This Project Grant award of $999,996.00 from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) is supporting research at the University of Illinois to investigate the mechanism governing the association between viral respiratory infection relapse and disease progression in persons with multiple sclerosis (MS). The research aims to transform health care for service members and the American public through innovative and impactful research, as...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
The Defense Health Agency awarded a $553,588 Project Grant to Michigan State University on September 1, 2023 to conduct research on "NEUROBIOLOGICAL MECHANISMS TO ALLEVIATE COMORBID PAIN AND OBESITY." This Project Grant is funded through the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As the prime awardee, Michigan State University...
The Michigan State University was awarded a $704,249 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2021 to June 2024 to uncover mechanisms underlying cognitive changes and sleep in neurofibromatosis type 1 (NF1). The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This federal Project Grant award, valued at $616,000.00 and provided by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), aims to evaluate the feasibility of inhibiting the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme as a countermeasure to mitigate the neurological effects of organophosphate nerve agent exposure. The University of Tennessee Health Science Center, a leading non-profit research institution, is the primary awardee for...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
The University of Rochester was awarded a $601,496 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of the grant is to provide "Mechanistic Insight into the Airborne Hazards Exposure-Related Development of Neurological Disorders." The research conducted under this 3-year grant, from August 1, 2024 to July 31, 2027, will investigate the underlying biological mechanisms by which exposure to...